Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma.

Conclusion: Quantification of cfDNA with qPCR at the time of diagnosis may allow identification of patients with high cfDNA concentration, which correlates with aggressive clinical outcomes and adverse prognosis. PMID: 31309089 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research